SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-002120
Filing Date
2017-01-27
Accepted
2017-01-27 17:51:10
Documents
2
Period of Report
2017-01-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4043
2 EX-24 DOCUMENT attachment1.htm EX-24 4077
  Complete submission text file 0000899243-17-002120.txt   9516
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Issuer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 711 HARVEST HILL ROAD CHALFONT PA 18914
Business Address
Pomerantz Roger (Reporting) CIK: 0001614936 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37465 | Film No.: 17554936